117 related articles for article (PubMed ID: 23934461)
1. Transarterial chemoembolization for treatment of hepatocellular carcinoma: A single center experience.
Idilman I; Peynircioğlu B; Cil BE; Doğanay Erdoğan B; Yalçın S; Bayraktar Y; Kav T; Altundağ K; Balkancı F
Turk J Gastroenterol; 2013; 24(2):141-7. PubMed ID: 23934461
[TBL] [Abstract][Full Text] [Related]
2. Objective Tumor Response of Hepatocellular Carcinoma Obtained by Transarterial Radioembolization with Iodine-131-Lipiodol Versus Transarterial Chemoembolization for Patients with and without Portal Venous Thrombosis: A Controlled Interventional Trial.
Oliveira Ribeiro MC; Moda KA; Alvarez M; Koga KH; Moriguchi SM; Carvalho FC; Pinheiro RSN; Qi X; Romeiro FG
Acad Radiol; 2024 May; 31(5):1839-1848. PubMed ID: 38016824
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Transarterial Chemoembolization With Sorafenib for Portal Vein Tumor Thrombus: A Randomized Clinical Trial.
Peng Z; Fan W; Liu Z; Xiao H; Wu J; Tang R; Tu J; Qiao L; Huang F; Xie W; Zhuang W; Guo W; Li S; Hua Y; Shen S; He Q; Li D; Li J; Kuang M
JAMA Surg; 2024 Jun; 159(6):616-624. PubMed ID: 38568599
[TBL] [Abstract][Full Text] [Related]
4. A comparison of carbon ion radiotherapy and transarterial chemoembolization treatment outcomes for single hepatocellular carcinoma: a propensity score matching study.
Shiba S; Shibuya K; Katoh H; Kaminuma T; Miyazaki M; Kakizaki S; Shirabe K; Ohno T; Nakano T
Radiat Oncol; 2019 Aug; 14(1):137. PubMed ID: 31375120
[TBL] [Abstract][Full Text] [Related]
5. Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma.
Chang Y; Jeong SW; Young Jang J; Jae Kim Y
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142892
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization for pulmonary or mediastinal metastases from hepatocellular carcinoma.
Hori A; Ohira R; Nakamura T; Kimura Y; Ueda S; Torii M; Kennoki N; Hori S
Br J Radiol; 2020 Jun; 93(1110):20190407. PubMed ID: 32142364
[TBL] [Abstract][Full Text] [Related]
7. Surgical resection is better than transarterial chemoembolization for hepatocellular carcinoma beyond Milan criteria independent of performance status.
Liu PH; Lee YH; Hsu CY; Hsia CY; Huang YH; Chiou YY; Lin HC; Huo TI
J Gastrointest Surg; 2014 Sep; 18(9):1623-31. PubMed ID: 24871082
[TBL] [Abstract][Full Text] [Related]
8. Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor model.
Doemel LA; Santana JG; Savic LJ; Gaupp FML; Borde T; Petukhova-Greenstein A; Kucukkaya AS; Schobert IT; Hamm CA; Gebauer B; Walsh JJ; Rexha I; Hyder F; Lin M; Madoff DC; Schlachter T; Chapiro J; Coman D
Eur Radiol; 2022 Apr; 32(4):2437-2447. PubMed ID: 34718844
[TBL] [Abstract][Full Text] [Related]
9. Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma.
Iezzi R; Posa A; Valente I; Contegiacomo A; Zocco MA; Pompili M; Annicchiarico BE; Ponziani FR; Basso M; Goldberg SN; Giuliante F; Gasbarrini A; Sala E;
Radiol Med; 2024 May; 129(5):807-816. PubMed ID: 38512624
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of Drug-eluting Beads Transarterial Chemoembolization for Unresectable Gastric Carcinoma.
Bi Y; Ren J; Han X
J Gastrointest Surg; 2023 Nov; 27(11):2577-2579. PubMed ID: 37407896
[No Abstract] [Full Text] [Related]
11. Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization.
Mendiratta-Lala M; Aslam A; Bai HX; Chapiro J; De Baere T; Miyayama S; Chernyak V; Matsui O; Vilgrain V; Fidelman N
Eur Radiol; 2024 May; 34(5):3284-3297. PubMed ID: 37930412
[TBL] [Abstract][Full Text] [Related]
12. Phase I Dose-Escalation Study of Tirapazamine Chemoembolization for Unresectable Early- and Intermediate-Stage Hepatocellular Carcinoma.
Liu CH; Peng CM; Hwang JI; Liang PC; Chen PJ; Abi-Jaoudeh N; Giiang LH; Tyan YS
J Vasc Interv Radiol; 2022 Aug; 33(8):926-933.e1. PubMed ID: 35504436
[TBL] [Abstract][Full Text] [Related]
13. A commentary on 'Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study'.
Gao F; Zhao X; Xie Q; Yang J; Wu H
Int J Surg; 2024 Apr; 110(4):2442-2443. PubMed ID: 38215248
[No Abstract] [Full Text] [Related]
14. Outcomes of children with hepatoblastoma who underwent liver resection at a tertiary hospital in China: a retrospective analysis.
Li J; Li H; Wu H; Niu H; Li H; Pan J; Yang J; Tan T; Hu C; Xu T; Zhang X; Zheng M; Li K; Zou Y; Yang T
BMC Pediatr; 2020 May; 20(1):200. PubMed ID: 32386507
[TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association.
Cho Y; Choi JW; Kwon H; Kim KY; Lee BC; Chu HH; Lee DH; Lee HA; Kim GM; Oh JS; Hyun D; Lee IJ; Rhim H;
Clin Mol Hepatol; 2023 Jul; 29(3):521-541. PubMed ID: 37482892
[TBL] [Abstract][Full Text] [Related]
16. C-Arm Computed Tomographic Image Fusion for Repetitive Transarterial Chemoembolization of Hepatocellular Carcinoma.
Choi Y; Jeong YS; Hwang JS; Kim HC; Chung JW; Choi JW
J Comput Assist Tomogr; 2023 Sep-Oct 01; 47(5):682-688. PubMed ID: 37707396
[TBL] [Abstract][Full Text] [Related]
17. Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma.
Shiba H; Ishida Y; Wakiyama S; Sakamoto T; Misawa T; Yanaga K
Cancer Sci; 2008 Oct; 99(10):2104-5. PubMed ID: 19016772
[TBL] [Abstract][Full Text] [Related]
18. Unusual upper gastrointestinal bleeding following radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma.
Chang CW; Wang HW; Huang WH; Chuang PH
J Postgrad Med; 2023; 69(4):237-238. PubMed ID: 36861547
[No Abstract] [Full Text] [Related]
19. Re-188 lipiodol in hepatocellular carcinoma with portal vein thrombosis: a pilot study using novel chelating agent N-DEDC and its comparison with (A)HDD.
Datta Gupta SS; Shamim SA; Gamanagatti S; Gupta P; Khan MA; Mallia MB; Chirayil V; Dash A; Bal C
Nucl Med Commun; 2024 Jun; 45(6):510-518. PubMed ID: 38632971
[TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis.
Sui WF; Li JY; Fu JH
World J Clin Oncol; 2024 Mar; 15(3):447-455. PubMed ID: 38576592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
